Alphavirus and alphavirus replicon particle formulations and methods

Details for Australian Patent Application No. 2007317347 (hide)

Owner Alphavax, Inc.

Inventors Depaz, Roberto A.; Talarico, Todd L.

Agent Wrays

Pub. Number AU-A-2007317347

PCT Pub. Number WO2008/058035

Priority 60/864,366 03.11.06 US

Filing date 2 November 2007

Wipo publication date 15 May 2008

International Classifications

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/058035 Priority application(s): WO2008/058035

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007317349-Compounds and compositions as protein kinase inhibitors

2007317340-Apparatus and methods for minimally invasive obesity treatment